SDJ
- 产品代码
- SDJ
- 器械名称
- Adjunctive Cardiac Amyloidosis Status Indicator
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 870.2200
- FDA 专业组
- Cardiovascular
- 上市路径
- 需提交 510(k) 上市前通告
- 该代码近三年的 510(k)
- 3 件
FDA 分类定义
The adjunctive cardiac amyloidosis status indicator is a prescription device based on sensor technology or image data to provide information to an interpreting clinician in detecting cardiac amyloidosis. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
该代码近三年的 510(k)(3 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| K250151 | 2025-06-20 | Eko.Ai Pte Ltd. D/B/A Us2.Ai | Us2.ca | |
| K243866 | 2025-05-21 | InVision Medical Technology Corporatio | InVision Precision Cardiac Amyloid | |
| K240860 | 2024-11-15 | Ultromics Limited | EchoGo Amyloidosis (1.0) |
FDA 官方分类页: SDJ
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。